Background: Neuropathological studies indicate concomitant Alzheimer's disease (AD)
pathology in patients with dementia with Lewy bodies (DLB). Objectives: To measure …

A significant proportion of patients with dementia with Lewy bodies (DLB) show Alzheimer's
disease (AD) pathology like senile plaques and neurofibrillary tangles. Biomarkers in …

Abstract Dementia with Lewy Bodies (DLB) is the second most common form of dementia
after Alzheimer's disease (AD), accounting for 15% to 20% of neuropathologically defined …

Background Differential diagnosis between dementia with Lewy bodies (DLB) and
Alzheimer's disease (AD) is not straightforward, especially in the early stages of disease. We …

Background: Dementia with Lewy bodies (DLB) symptoms are close to those of Alzheimer's
disease (AD), and the differential diagnosis is difficult especially early in the disease …

Aim To explore associations of cerebrospinal fluid biomarkers of neurodegeneration and
amyloidosis with caregiver burden, cognition and functionality in dementia with Lewy bodies …

Abstract Objective Dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD) may be viewed as different points on a continuum reflecting the regional burden and …

Background: Dementia with Lewy bodies (DLB) is difficult to differentiate from other neuro-
degenerative diseases. Patients are often mistaken to suffer from Parkinson's disease (PD) …

Objective The presence of concomitant Alzheimer pathology has been linked to earlier
death in cases with dementia with Lewy bodies (DLB). Recently, elevated cerebrospinal …

Background One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is
the common co-morbid presence of amyloid pathology. To understand the putative role of …